Diseases

Scancell, PharmaJet sign agreement for melanoma vaccine delivery system
By LabPulse.com staff writers
Clinical-stage biopharmaceutical company Scancell has signed a strategic partnership agreement with PharmaJet for the supply of PharmaJet's needle-free Stratis delivery system for the delivery of Scancell's advanced melanoma vaccine.
September 18, 2024
Business Agreement Social
FDA clears marketing T2 Biosystems Candida test for pediatrics
By LabPulse.com staff writers
T2Candida Panel may get a boost.
September 16, 2024
Candida Candidiasis Social
Rapid diagnostic test developed for ALS
By LabPulse.com staff writers
A blood diagnostic test for amyotrophic lateral sclerosis (ALS) has been developed that can rapidly distinguish ALS from conditions that mimic ALS in its early stages with a high level of specificity and sensitivity.
September 13, 2024
Nerve Neuron Axon Social
AI model shows promise for 'virtual staining' of cancerous tissue
By LabPulse.com staff writers
Researchers have created an artificial intelligence (AI) model that generates images showing virtual colorations of cancerous tissue.
September 12, 2024
Pathology Digital Workstation Microscope Social
LuminUltra acquires Genomadix Legionella test assets
By LabPulse.com staff writers
LuminUltra has acquired the Legionella testing business assets of Genomadix, as well as the rights to develop and commercialize further assays and test methods.
September 10, 2024
Water Social
Seegene launches 3rd RUO mpox assay
By LabPulse.com staff writers
After introducing two research use only (RUO) mpox assays in August, Seegene has expanded its mpox assay line with a third RUO assay designed to address the spread of the mpox virus variant clade Ib currently prevalent in the mpox outbreak in Africa.
September 10, 2024
3 D Monkeypox Infecting Cell Social
A. Menarini, Nucleix sign distribution agreement for bladder cancer test
By LabPulse.com staff writers
A. Menarini Diagnostics and liquid biopsy firm Nucleix have signed a strategic partnership for the exclusive distribution of Nucleix's Bladder EpiCheck test.
September 9, 2024
Bladder Urinary 3 D Social
Rapid blood test for heart attack holds promise for shorter ED stays
By LabPulse.com staff writers
A rapid blood test that can distinguish heart attack in people presenting at emergency departments (EDs) with chest pain has been developed by researchers.
September 5, 2024
Heart Ekg Social
Hitachi High-Tech, Gencurix forge agreement on cancer diagnostics
By LabPulse.com staff writers
Hitachi High-Tech and oncology molecular diagnostics firm Gencurix have formed a strategic partnership aimed at developing cancer diagnostics and testing services.
August 30, 2024
Hands Shaking2 Social
AI-guided rapid Lyme disease test shows promise for early detection
By LabPulse.com staff writers
A new test under development that uses artificial intelligence (AI) and a format similar to that of at-home COVID-19 tests has been shown to accurately identify Lyme disease within 20 minutes.
August 29, 2024
Ticks Sign Social
Upcoming lung cancer molecular testing guidelines address 7 questions
By Liz Carey
Revised guideline addresses next-generation sequencing and expanded biomarker testing.
August 28, 2024
Lung Cancer Hotspot Social
CDC prioritizes mpox specimens for testing laboratories
By LabPulse.com staff writers
The CDC recommended that all laboratories performing mpox testing send certain types of clinical specimens to a laboratory that can perform clade-specific testing as quickly as possible.
August 28, 2024
Monkeypox Virus Social
Page 1 of 289
Next Page